Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition

Alice P. Pentland, John W. Schoggins, Glynis A. Scott, Kanwar Nasir M Khan, Rujing Han

Research output: Contribution to journalArticle

288 Scopus citations

Abstract

UV light is a complete carcinogen, inducing both basal and squamous cell skin cancers. The work described uses the selective COX-2 inhibitor celecoxib to examine the efficacy of COX-2 inhibition in the reduction of UV light-induced skin tumor formation in hairless mice. UVA-340 sun lamps were chosen as a light source that effectively mimics the solar UVA and UVB spectrum. Hairless mice were irradiated for 5 days a week for a total dose of 2.62 J/cm2. When 90% of the animals had at least one tumor, the mice were divided into two groups so that the tumor number and multiplicity were the same (P < 0.31). Half of the mice were then fed a diet containing 1500 p.p.m. celecoxib. Tumor number, multiplicity and size were then observed for the next 10 weeks. Ninety-five percent of the tumors formed were histopathologically evaluated as squamous cell carcinoma. COX-2 expression and activity were increased in tumors. After 10 weeks, the difference in tumor number and multiplicity in the drug-treated group was 56% of UV controls (P < 0.001). The results show that the orally administered selective COX-2 inhibitor celecoxib prevents new tumor formation after the onset of photocarcinogenesis and suggest that treatment with celecoxib may be very useful in preventing UV-induced skin tumors in humans.

Original languageEnglish (US)
Pages (from-to)1939-1944
Number of pages6
JournalCarcinogenesis
Volume20
Issue number10
DOIs
StatePublished - Oct 21 1999

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition'. Together they form a unique fingerprint.

  • Cite this